Psoriasis Treatment Market is Expected to Reach $35.07 Billion by 2031, at a CAG
Psoriasis Treatment Market Size, Share, Forecast, & Trends Analysis by Treatment (TNF Inhibitor, Interleukin, Corticosteroids, Calcitrol, Retinoids, Calcineurin, Methotrexate) Disease (Plaque Psoriasis, Psoriatic Arthritis) \u2013 Global Forecast to 2031\n
0 views • 5 slides
Psoriasis Treatment Market: Exploring the Impact of Lifestyle and Dietary Change
Psoriasis Treatment Market Size, Share, Forecast, & Trends Analysis by Treatment (TNF Inhibitor, Interleukin, Corticosteroids, Calcitrol, Retinoids, Calcineurin, Methotrexate) Disease (Plaque Psoriasis, Psoriatic Arthritis) \u2013 Global Forecast to
0 views • 3 slides
Methotrexate-Related Leukoencephalopathy in a Teenager with T-cell ALL
A 16-year-old female with T-cell ALL presented with acute right-sided weakness and slurred speech. Differential diagnoses included stroke, asparaginase toxicity, viral infections, and methotrexate neurotoxicity. Imaging revealed an area of restricted diffusion in the centrum semiovale, characteristi
0 views • 20 slides